TFA Therapeutics RAJAF
OTC RAJAF
$9.18 +0.00 (+0.00%)
At close: Sep 8, 2026 · 4:00 PM EDT

TFA Therapeutics (RAJAF) Raw Materials (2021 - 2022)

TFA Therapeutics (RAJAF) posted Raw Materials of $12823.0 for Q4 2022, down 7.6% on a QoQ basis from $13878.0 in Q4 2021, and down 7.6% year-over-year from $13878.0 in Q4 2021.

Analysis

TFA Therapeutics (RAJAF) Raw Materials (2021 - 2022) Analysis & Trends

TFA Therapeutics has reported Raw Materials for 2 years, with the latest figure at $12823.0 in Q4 2022.

  • On a quarterly basis, Raw Materials fell 7.6% year-over-year to $12823.0 in Q4 2022; TTM through Dec 2022 was $12823.0, a 7.6% decrease from a year earlier, with the FY2022 full-year figure at $12823.0, down 7.6% from the prior year.
  • Raw Materials was $12823.0 for Q4 2022 at TFA Therapeutics, down from $13878.0 in the prior quarter.
  • The five-year high for Raw Materials was $13878.0 in Q4 2021, with the low at $12823.0 in Q4 2022.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Colgate Palmolive 70.23 Bn 68.86 Bn 3.30 Bn
2 Kenvue 34.13 Bn 33.02 Bn 2.30 Bn
3 Kimberly Clark 32.73 Bn 31.77 Bn 1.60 Bn
4 Bath & Body Works 3.77 Bn 2.98 Bn 692.00 Mn
5 Prestige Consumer Healthcare 2.27 Bn 2.21 Bn -
6 Perrigo 1.89 Bn 1.49 Bn 313.90 Mn
7 Herbalife 1.28 Bn 905.45 Mn 1.03 Bn
8 Edgewell Personal Care 1.24 Bn 840.59 Mn 242.50 Mn
9 TFA Therapeutics 1.02 Bn 1.02 Bn -
10 Honest Company 586.90 Mn 481.00 Mn 40.36 Mn
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2022 12,823.00
Dec 31, 2021 13,878.00